Increased sensitivity to theophylline associated with primary open-angle glaucoma.
D002986:Clinical Trials as Topic; D000242:Cyclic AMP / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D003907:Dexamethasone; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology*; D005901:Glaucoma / Q000235:genetics*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects; D008661:Metabolism, Inborn Errors / Q000150:complications; D009883:Ophthalmic Solutions; D010710:Phosphates / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D009883:Ophthalmic Solutions; D010710:Phosphates; D014316:Tritium; D003907:Dexamethasone; D004247:DNA; D011239:Prednisolone; D013806:Theophylline; D000242:Cyclic AMP; D013936:Thymidine